Serum free light chain measurement in patients with multiple myeloma and amyloidosis AL

被引:0
|
作者
Dellerba, MP [1 ]
James, M [1 ]
Butler, SJ [1 ]
Kelsey, PR [1 ]
机构
[1] Victoria Hosp, Dept Clin Biochem, Blackpool FY3 8NR, England
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:S137 / S137
页数:1
相关论文
共 50 条
  • [41] Serum Free Light Chain Ratio in Distinguishing Smoldering Multiple Myeloma From Active Multiple Myeloma
    Larsen, Jeremy T.
    Kumar, Shaji
    Rajkumar, S. Vincent
    BLOOD, 2011, 118 (21) : 1688 - 1688
  • [42] Free light chain (FLC) assays in the management of patients with AL amyloidosis
    Merlini, Giampaolo
    Palladini, Giovanni
    BIOCHIMICA CLINICA, 2013, 37 (05) : 347 - 351
  • [43] Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio
    Prokaeva, Tatiana
    Spencer, Brian
    Sun, Fangui
    O'Hara, Richard M.
    Seldin, David C.
    Connors, Lawreen H.
    Sanchorawala, Vaishali
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2016, 23 (04): : 214 - 220
  • [44] Light chain multiple myeloma: when the response will it be evaluated by serum free light chains?
    Corre, Jill
    Avet-Loiseau, Herve
    Hematologie, 2016, 22 (06): : 393 - 394
  • [45] Management of patients with light chain myeloma using serum free light chain immunoassays.
    Bradwell, AR
    Carr-Smith, HD
    Mead, GF
    Harvey, TC
    CLINICAL CHEMISTRY, 2002, 48 (06) : A17 - A18
  • [46] ANALYSIS OF FREE LIGHT CHAINS (FLCS) LEVEL IN PATIENTS (PTS) SUFFERING FROM MULTIPLE MYELOMA (MM) COMPLICATED WITH AMYLOIDOSIS ANTIBODY LIGHT (AL AMYLOIDOSIS)
    Usnarska-Zubkiewicz, L.
    Holojda, J.
    Debski, J.
    Kuliczkowski, K.
    HAEMATOLOGICA, 2012, 97 : 623 - 623
  • [47] Utility of the Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart Failure
    Chang, Ian C.
    Dispenzieri, Angela
    Scott, Christopher G.
    Lin, Grace
    Jaffe, Allan S.
    Klarich, Kyle W.
    Grogan, Martha
    MAYO CLINIC PROCEEDINGS, 2019, 94 (03) : 447 - 454
  • [48] Multiple Myeloma with Systemic Amyloidosis: Serum Free Light Chain Dimerization Analysis in the Diagnosis of an Equivocal Case of Plasma Cell Dyscrasia
    Duek, Adrian
    Kaplan, Batia
    Segman, Yafit
    Leiba, Merav
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2021, 23 (07): : 459 - 461
  • [49] Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis
    Sidana, Surbhi
    Narkhede, Mayur
    Elson, Paul
    Hastings, Debbie
    Faiman, Beth
    Valent, Jason
    Samaras, Christy
    Hamilton, Kimberly
    Liu, Hien K.
    Smith, Mitchell R.
    Reu, Frederic J.
    PLOS ONE, 2017, 12 (03):
  • [50] Splenic rupture secondary to amyloid light-chain (AL) amyloidosis associated with multiple myeloma
    Buzalewski, Jarrod
    Fisher, Matthew
    Rambaran, Ryan
    Lopez, Richard
    JOURNAL OF SURGICAL CASE REPORTS, 2019, (03):